Skip to main content
. 2023 Dec 21;6(4):100991. doi: 10.1016/j.jhepr.2023.100991

Table 3.

Tumor response rates determined by RECIST version 1.1.

Best response
Objective response, n (%) 18 (36.0; 24.7–48.6)
 Complete response 4 (8.0)
 Partial response 14 (28.0)
Stable disease, n (%) 19 (38.0)
Disease control rate, n (%) 37 (74.0; 61.9–83.9)
Progressive disease, n (%) 11 (22.0)
Not evaluable, n (%) 2 (4.0)
Patients with an ongoing response, n (%) 7 (14.0)
Duration of response, median [IQR], months 9.9 [3.6-18.6]

90% confidence interval, shown in parentheses, was calculated using the Clopper-Pearson exact method. Seven patients maintained a response (CR or PR) at the time of study closure.